Showing 1221-1230 of 1697 results for "".
Cannabis, Cannabidiol, and Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/cannabis-cannabidiol-and-epilepsy/30180/A new frontier brings new questions and old dilemmas.Are Anti-amyloid Therapies Still Worth Being Developed as Treatments for Alzheimer's Disease?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/are-anti-amyloid-therapies-still-worth-being-developed-as-treatments-for-alzheimers-disease/30832/Despite limited pharmaceutical success thus far, amyloid peptides may yet prove useful in the treatment of Alzheimer's and delay disease progression.News
https://practicalneurology.com/columns/practice-management/news/30537/Blood and Cerebrospinal Fluid Biomarkers in Amyotrophic Lateral Sclerosis: Current Landscape and Potential Utility in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/blood-and-cerebrospinal-fluid-biomarkers-in-amyotrophic-lateral-sclerosis-current-landscape-and-potential-utility-in-clinical-practice/35542/Amyotrophic lateral sclerosis biomarkers are increasingly shaping the development of new treatments.Epilepsy Essentials: Novel Interictal Biomarkers for Delineating the Epileptogenic Zone in Children With Drug-Resistant Epilepsy
https://practicalneurology.com/programs/practical-neurology-focus-on-epilepsy-seizures/epilepsy-essentials-novel-interictal-biomarkers-for-delineating-the-epileptogenic-zone-in-children-with-drug-resistant-epilepsy/32147/Novel interictal biomarkers of epilepsy are able to identify the epileptogenic zone with precision and predict surgical outcome in children with drug-resistant epilepsy.Updates in Diagnostic Testing in Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/updates-in-diagnostic-testing-in-parkinson-disease/32164/A review of diagnostic tests for Parkinson disease, including DAT-SPECT, α-synuclein skin biopsy and CSF studies, and genetic testing, offering guidance on their appropriate use and interpretation.Myasthenia Gravis: Making Progress for More Accurate Diagnoses and Targeted Treatments
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-making-progress-for-more-accurate-diagnoses-and-targeted-treatments/32114/Advances in testing and treatments for myasthenia gravis are leading to more accurate diagnoses and improvements in symptom control for individuals with this rare chronic autoimmune disease.Fatigue in Multiple Sclerosis: A Comprehensive Approach to Evaluation and Management
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/fatigue-in-multiple-sclerosis-a-comprehensive-approach-to-evaluation-and-management/32087/Management of fatigue in multiple sclerosis requires a holistic approach tailored to the individual.Immunomodulation for Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/immunomodulation-for-parkinson-disease/31827/Multiple immunomodulators are being evaluated for potential treatment of Parkinson disease.Genetically Targeted Therapies for Inherited Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetically-targeted-therapies-for-inherited-neuromuscular-disorders/31816/Targeted genetic therapies for neuromuscular disorders have ushered in a new era with still unresolved clinical, ethical, and economic questions to address.